Legal Representation
Attorney
Molly B. Markley
USPTO Deadlines
Next Deadline
1312 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-14)
Due Date
February 14, 2029
Grace Period Ends
August 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 14, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 14, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Nov 29, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 29, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 9, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 25, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 24, 2022 | ALIE | A | ASSIGNED TO LIE |
| Oct 24, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 24, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 13, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 11, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 11, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Apr 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 21, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 22, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical preparations in the form of a powder for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; pharmaceutical preparations in the form of a powder for medical purposes for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; biological preparations in the form of a powder for medical purposes for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; pharmaceutical preparations formulated for pulmonary delivery via inhalation for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; pharmaceutical preparations in the form of a powder for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems; inhalers filled with biological preparations in the form of powder for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; metered dose inhalers filled with biological preparations in the form of powder for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; active dry powder inhalers filled with biological preparations in the form of powder for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems; passive dry powder inhalers filled with biological preparations in the form of powder for the treatment of pulmonary conditions and diseases of the repiratory and cardiovascular systems
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Inhalers for medical use sold empty; metered dose inhalers for medical use sold empty; active dry powder inhalers for medical use sold empty; passive dry powder inhalers for medical use sold empty
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO